Joseph W. la Barge

Directeur Général chez Apertura Gene Therapy LLC

Profil

Joseph W.
la Barge is Chief Executive Officer at Apertura Gene Therapy LLC since 2022.
Holds director positions at Life Sciences Pennsylvania, National Pharmaceutical Council since 2018, and Spark Therapeutics UK Ltd. Formerly served as VP, General Counsel & Assistant Secretary at PMA Cos., Inc. in 2006.
Served as Vice President & General Counsel at Tengion, Inc. in 2010.
Worked as Of Counsel at Ballard Spahr LLP in 2004.
Held the position of Deputy General Counsel at Jefferson Cherry Hill Hospital in 2013.
Was Chief Business Officer at Spark Therapeutics, Inc. from 2020 to 2021.
Completed undergraduate studies at Bucknell University and graduate studies at Temple University (Pennsylvania).

Postes actifs de Joseph W. la Barge

Sociétés	Poste	Début
Life Sciences Pennsylvania	Directeur/Membre du Conseil	-
National Pharmaceutical Council	Directeur/Membre du Conseil	06/03/2018
Spark Therapeutics UK Ltd.	Directeur/Membre du Conseil	11/12/2018
Apertura Gene Therapy LLC	Directeur Général	14/07/2022

Anciens postes connus de Joseph W. la Barge

Sociétés	Poste	Fin
SPARK THERAPEUTICS, INC.	Conseiller Juridique Général	01/01/2020
Jefferson Cherry Hill Hospital	Corporate Officer/Principal	-
Ballard Spahr LLP	Conseiller Juridique Général	01/01/2004
TENGION, INC.	Compliance Officer	-
PMA Cos., Inc.	Conseiller Juridique Général	01/11/2006